[MYGN] YoY Quarter Result on 31-Dec-2015 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
03-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- 13.91%
YoY- 26.09%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 216,800 194,000 196,500 193,300 184,393 204,060 149,140 6.43%
PBT 3,600 3,700 12,100 45,000 37,940 84,144 56,985 -36.87%
Tax 1,000 -28,400 6,200 14,700 13,909 33,784 21,949 -40.22%
NP 2,600 32,100 5,900 30,300 24,031 50,360 35,036 -35.16%
Tax Rate -27.78% 767.57% -51.24% -32.67% -36.66% -40.15% -38.52% -
Total Cost 214,200 161,900 190,600 163,000 160,362 153,700 114,104 11.06%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 1.20 16.55 3.00 15.68 13.03 24.68 23.49 -39.07%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS 0.04 0.46 0.09 0.43 0.33 0.67 0.43 -32.67%
EPS Diluted 0.03 0.45 0.09 0.41 0.32 0.66 0.42 -35.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.